ZHANG Jing-ying, XIE Cong. A Case of Sever Adverse Reactions Caused by Methotrexate Combined with Mifepristone in the Treatment of Ectopic Pregnancy[J]. Journal of International Obstetrics and Gynecology, 2025, 52(5): 589-591.
Po L, Thomas J, Mills K, et al. Guideline No. 414: Management of Pregnancy of Unknown Location and Tubal and Nontubal Ectopic Pregnancies[J]. J Obstet Gynaecol Can, 2021, 43(5):614-630.e1.doi: 10.1016/j.jogc.2021.01.002.
pmid: 33453378
Su Q, Feng H, Tian T, et al. The efficacy of mifepristone combined with methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis[J]. Ann Med, 2022, 54(1):3269-3285. doi: 10.1080/07853890.2022.2136747.
pmid: 36382690
[4]
Dealberti D, Franzò S, Bosoni D, et al. The Use of Methotrexate and Mifepristone for Treatment of Interstitial Pregnancies: An Overview of Effectiveness and Complications[J]. J Clin Med, 2023, 12(23):7396. doi: 10.3390/jcm12237396.
Bielack SS, Soussain C, Fox CP, et al. A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment[J]. J Cancer Res Clin Oncol, 2024, 150(10):441. doi: 10.1007/s00432-024-05945-6.
pmid: 39356310
[7]
Karena ZV, Shah H, Vaghela H, et al. Clinical Utility of Mifepristone: Apprising the Expanding Horizons[J]. Cureus, 2022, 14(8):e28318. doi: 10.7759/cureus.28318.
[8]
Hamed KM, Dighriri IM, Baomar AF, et al. Overview of Methotrexate Toxicity: A Comprehensive Literature Review[J]. Cureus, 2022, 14(9):e29518. doi: 10.7759/cureus.29518.
[9]
Shafie M, Abbaszadeh M, Sharifi F. Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction[J]. Daru, 2021, 29(1):205-209. doi: 10.1007/s40199-020-00379-0.
pmid: 33409982